AstraZeneca in $1.15B Deal for Pearl Therapeutics

June 10 (Bloomberg) -- Bloomberg's Anna Edwards reports that AstraZeneca has agreed to a $1.15 billion deal to buy Pearl Therapeutics, a maker of therapies for respiratory disease. She speaks on Bloomberg Television's "Countdown."

Google Search: Crystal Ball for Election Results?
22:23 - Khosla Ventures partner Keith Rabois, Braintree head of commerce Harper Reed and Bloomberg’s Tim Higgins discuss how campaigns can use Google search data with Emily Chang on “Bloomberg West.” (Source: Bloomberg)
  • Apple Said to Produce New Show Starring Dr. Dre
  • Can PayPal Commerce Stand Up to Competition?
  • How Medium Recruits High Profile Writers